A. Epidemiology update:

Slides:



Advertisements
Similar presentations
ATRIAL FIBRILLATION CONTINUUM OF CARE
Advertisements

Ali Alsayegh, MD, FRCPC,FACC Consultant Cardiologist, Consultant Cardiac Electrophysiologist.
Atrial Fibrillation and Sudden Death: Are they linked? Mariell Jessup MD Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania.
Peking University Dayi Hu Sept 16, IHF,Beijing, 2005 Atrial Fibrillation in China.
1 Key points – Heart Failure within Bradford 2011.
Understanding Risk Professor Dan Atar, MD, FESC Dept. of Cardiology
1 Clinical Overview of Atrial Fibrillation Edward L.C. Pritchett, M.D. Consulting Professor of Medicine Divisions of Cardiology and Clinical Pharmacology.
Cardioversion of Atrial Fibrillation Clinical Issues Christopher Granger, MD Director, Cardiac Care Unit Duke University Medical Center December 2007.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Heart Failure Ben Starnes MD FACC Interventional Cardiology
S. HUNT Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010.
To know more visit HeartFailure.com © 2015 Novartis Pharma AG, May 2015, GLCM/HTF/0028 HEART FAILURE MORTALITY STATISTICS.
VBWG In-hospital course of stroke patients with vs without AF Steger C et al. Eur Heart J. 2004;6:in press. More severe stroke on admission Lower Barthel.
CHADS, SHMADS: What’s All This About Anticoagulation? COPYRIGHT © 2016, ALL RIGHTS RESERVED From the Publishers of.
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
Date of download: 5/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA/ESC guidelines for the management of patients.
THE HEART’S ELECTRICAL SYSTEM Marco Perez, MD Center for Inherited Cardiovascular Disease Inherited Cardiac Arrhythmia Clinic June 20, 2013.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Inappropriate Implantable Cardioverter-Defibrillator.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Habitual Coffee Consumption on Cardiometabolic.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA/ESC 2006 Guidelines for Management of Patients.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. Benefit of Anticoagulation Unlikely in Patients With Atrial.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2014 AHA/ACC/HRS Guideline for the Management of.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA/ESC 2006 Guidelines for the Management of.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Sex Differences in Hospital Mortality in Adults With.
Findings suggest: Improvement was noted in both BMI and reported physical activity although the differences did not reach statistical difference. Behavior.
Date of download: 7/10/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Prevalence of Diagnosed Atrial Fibrillation in Adults:
Primary Mitral Regurgitation Degenerative Mitral Valve Disease
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2016 ACC Expert Consensus Decision Pathway on the.
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Epidemiology and natural history of atrial fibrillation:
Risk With Atrial Fibrillation: A Guy Thing?
Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated with Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.
Stepwise approach to assessing cardiac patient risk for noncardiac surgery. (Reproduced, with permission, from Fleisher LA et al. ACC/AHA 2007 Guidelines.
Stepwise approach to assessing cardiac patient risk for noncardiac surgery. (Reproduced, with permission, from Fleisher LA et al. ACC/AHA 2007 Guidelines.
Landon Marshall, Pharm. D. , Matt Hill, Pharm. D. , Jim Wilson, Pharm
Copyright © 2012 American Medical Association. All rights reserved.
Exploring Factors Associated with Preferential Prescribing of Apixaban Over Warfarin in Patients with Non-Valvular Atrial Fibrillation Scott McColgana,
Major recommendation for statin therapy for ASCVD prevention
2014 Texas Pediatric Society Electronic Poster Contest
Screening and diagnosis of AF and stratifying stroke risk
Volume 77, Issue 12, Pages (June 2010)
No evidence that AF type significantly impacts stroke risk
Κολπικη μαρμαρυγη σε ασθενεις με αποφρακτικη υπνικη απνοια
Insights into the Importance of the Electrocardiogram in
Echocardiograms in syncope work-up
C. ACC/AHA/ESC guidelines Role of anticoagulant therapy in AF
Atrial fibrillation (AF) is defined in the most recent combined American College of Cardiology (ACC) / American Heart Association (AHA) / European Society.
Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control 
D. Current clinical options Warfarin: Issues and challenges
A. Epidemiology update:
Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.
Heart Disease and Stroke Statistics — 2004 Update
Stroke mechanisms in AF: Rationale for anticoagulant therapy
Reducing the Burden of Stage B Heart Failure and the Global Pandemic of Cardiovascular Disease: Time to Go to War with the “Barefoot” Troops!  Ragavendra.
A. Heart failure: A challenge to the healthcare delivery system
A: Epidemiology update
Section VII: Summary New focus on treating hypertension beyond the numbers Content Points: In view of current clinical understanding of the link between.
Nationwide epidemic of obesity
Reducing the Burden of Stage B Heart Failure and the Global Pandemic of Cardiovascular Disease: Time to Go to War with the “Barefoot” Troops!  Ragavendra.
Impact of risk factors and age of initiation of therapy on the distribution of lifespan gain. ‘National average risk’ refers to a cohort beginning at age.
Nazem Akoum, MD, MS, FACC, FHRS Associate Professor of Medicine
Statistical Challenges Related to Population Screening for AF Christine M. Albert, MD, MPH Director, Center for Arrhythmia Prevention, Brigham.
Pamela E. Scott et al. JACC 2018;71:
Section II: Lipid management
Potential effect of guidelines on ASCVD prevention in the CGPS*
Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.
Volume 77, Issue 12, Pages (June 2010)
Pharmacological management of patients with newly discovered atrial fibrillation. Pharmacological management of patients with newly discovered atrial fibrillation.
Pharmacological management of patients with recurrent paroxysmal atrial fibrillation. Pharmacological management of patients with recurrent paroxysmal.
Pharmacological management of patients with recurrent persistent or permanent atrial fibrillation. Pharmacological management of patients with recurrent.
Atrial Fibrillation: An Escalating Cardiovascular Disease With Significant Clinical and Economic Consequences.
Presentation transcript:

A. Epidemiology update: 1. Scope of the problem Nonvalvular AF: Issues and challenges Content Points: For the purposes of this slide kit, the term "AF" (atrial fibrillation) refers to arrhythmia not related to valvular heart disease (nonvalvular AF). AF is a supraventricular tachycardia characterized by uncoordinated atrial function.1 It may be isolated or associated with atrial flutter or atrial tachycardia. The atrial rate is 240 to 320 beats per minute (bpm). Two-to-one atrioventricular block is common, producing a ventricular rate of 120 to 160 bpm. This arrhythmia, the most commonly encountered in clinical practice and a major cause of cardioembolic stroke, is associated with a number of ongoing issues and related challenges. These are summarized on the slide. This slide kit addresses areas where progress is occurring, including mechanisms of AF-related stroke, risk stratification, and the role of anticoagulant therapy. 1Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force of Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation). J Am Coll Cardiol. 2001;38:1231-1265.

ATRIA: Prevalence of AF by age and sex Content Points: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study was a cross-sectional prevalence study in adults who were enrolled in a large California health maintenance organization (Kaiser Permanente of Northern California).1 In the study population of 1.89 million, a diagnosis of AF was entered in the medical records of 17,974 patients (0.95%) between July 1, 1996 and December 31, 1997. The prevalence of AF was greater in men than in women, and increased with age in both groups.   1Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. JAMA.2001;285:2370-2375.

ATRIA: Projected number of patients with AF Content Points: The ATRIA investigators estimated that 2.08 million Americans had AF during the period of cohort assembly and that this would rise to 5.61 million by 2050, an increase of approximately 2.5-fold.1 This increase reflects the projected increase in elderly individuals in the US population.   1Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. JAMA. 2001;285:2370-2375.

Hospitalizations for AF are increasing Content Points: Wattigney et al used data from the National Hospital Discharge Survey to study US trends in hospitalization for AF between 1985 and 1999.1 In this study, the investigators used ICD-9-CM diagnosis codes 42731 and 42732 to identify patients with AF. These codes include both AF and atrial flutter. Total hospitalizations for AF as the principal diagnosis increased from 154,086 to 376,487 (144% change). Hospitalizations for AF as a principal or secondary diagnosis followed a similar trend: 787,750 to 2,283,763 (190% change). As shown, while rates for individuals aged <64 years remained relatively level, the rates for individuals aged >65 years have risen.   1Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: Implications for primary prevention. Circulation. 2003;108:711-716.

Mortality and AF Content Points: Wolf et al conducted a prospective cohort study of 26,753 hospitalized patients with cardiovascular disease; 13,558 patients also had AF; 13,195 patients did not.1 The slide summarizes mortality rates by age and sex during the 3-year study period. Patients with AF had significantly higher mortality rates than matched patients without AF.   1Wolf PA, Mitchell JB, Baker CS, Kannel WB, D'Agostino RB. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med. 1998;158:229-234.